It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background:Mortality and major adverse cardiac events (MACE) frequently occur after percutaneous coronary intervention (PCI). Therefore, the ability to predict such events through an established risk stratification method is of great importance. The present study was aimed at determining the risk stratification of mortality and MACE in post-PCI patients at the intensive cardiac care unit of Cipto Mangunkusumo Hospital (CMH) using 7 variables of the New Mayo Clinic Risk Score (NMCRS).Method:This cross-sectional study drew upon secondary data gathered from the medical records of 313 patients that underwent PCI at the intensive cardiac care unit (ICCU) of CMH between August 1st, 2013, and August 31st, 2014. The primary end point was all-cause mortality and MACE. Seven variables in the NMCRS, namely age, left ventricular ejection fraction, serum creatinine, preprocedural cardiogenic shock, myocardial infarction, and peripheral arterial disease, were evaluated.Results:The mortality and MACE incidence rates in the post-PCI patients were 3.8% (95%CI: 2.6-5.0) and 8.3% (95% CI: 6.6-10.0), respectively. Regarding the NMCRS stratification, elderly patients with lower left ventricular ejection fraction, increased serum creatinine, preprocedural cardiogenic shock, myocardial infarction, and peripheral arterial disease had higher mortality and MACE incidence rates among the post-PCI patients. The mortality and MACE incidence rates significantly increased in the post-PCI patients with a higher NMCRS.Conclusion:Patients with a higher NMCRS had a tendency toward higher mortality and MACE incidence rates following PCI.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer